Savitz Ryan

CIK 00019923241 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001992324

Recent Transactions

31 trades

Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-07-09$21.77/sh+31,249→ 31,249 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-07-09−31,249→ 68,751 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-07-09$101.97/sh−5,566→ 0 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-07-09$101.24/sh−15,329→ 5,566 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-07-09$100.22/sh−10,354→ 20,895 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-04-09$89.84/sh−8,224→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-04-09−8,224→ 71,776 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-04-09$17.88/sh+8,224→ 8,224 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$80.25/sh−1,485→ 89,667 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$8.44/sh+74,367→ 74,367 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$17.88/sh+40,000→ 114,367 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$78.33/sh−1,390→ 112,977 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$78.86/sh−21,825→ 91,152 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$81.36/sh−800→ 88,867 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$82.84/sh−2,366→ 86,501 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$83.90/sh−59,800→ 26,701 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$84.57/sh−19,469→ 7,232 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-31$85.54/sh−7,232→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-31−74,367→ 10,399 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-31−40,000→ 80,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-02-03+150,000→ 150,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-12-04$8.44/sh+20,000→ 20,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-12-04+20,000→ 84,766 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-12-04$45.18/sh−20,000→ 0 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-09-23+60,000→ 60,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-09-09$8.44/sh+20,000→ 20,000 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-09-09$35.00/sh−20,000→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-09-09+20,000→ 104,766 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-02-03+150,000→ 150,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-05-23+100,000→ 100,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-01-24+120,000→ 120,000 total

Companies

Dianthus Therapeutics, Inc. /DE/
EVP, CFO & CBO
$DNTH

Recent Filings

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036

View on SEC.gov